Open Access
Open access
volume 13 issue 3 pages 1105-1123

Anticancer Properties of Lamellarins

Christian BAILLY 1
1
 
Pierre Fabre Research Institute, Research & Development Center, 3 Avenue Hubert Curien, BP 13562, 31035 Toulouse cedex 1, France
Publication typeJournal Article
Publication date2015-02-19
scimago Q1
wos Q1
SJR1.030
CiteScore10.1
Impact factor5.4
ISSN16603397
PubMed ID:  25706633
Drug Discovery
Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
Journal of Organic Chemistry
29 publications, 18.83%
Organic Letters
8 publications, 5.19%
Marine Drugs
6 publications, 3.9%
European Journal of Organic Chemistry
6 publications, 3.9%
Asian Journal of Organic Chemistry
6 publications, 3.9%
New Journal of Chemistry
6 publications, 3.9%
Molecules
5 publications, 3.25%
ChemistrySelect
4 publications, 2.6%
Organic Chemistry Frontiers
4 publications, 2.6%
Organic and Biomolecular Chemistry
4 publications, 2.6%
Heterocycles
4 publications, 2.6%
RSC Advances
3 publications, 1.95%
Russian Chemical Bulletin
3 publications, 1.95%
Tetrahedron Letters
3 publications, 1.95%
Tetrahedron
3 publications, 1.95%
Chemical Communications
3 publications, 1.95%
Synlett
3 publications, 1.95%
Current Organic Chemistry
2 publications, 1.3%
Chemistry of Heterocyclic Compounds
2 publications, 1.3%
Bioorganic and Medicinal Chemistry
2 publications, 1.3%
Bioorganic and Medicinal Chemistry Letters
2 publications, 1.3%
Advanced Synthesis and Catalysis
2 publications, 1.3%
ACS Catalysis
2 publications, 1.3%
Synthetic Communications
2 publications, 1.3%
Journal of Heterocyclic Chemistry
2 publications, 1.3%
Oncology Reports
1 publication, 0.65%
Future Medicinal Chemistry
1 publication, 0.65%
Journal of Chemical Research
1 publication, 0.65%
Biomolecules
1 publication, 0.65%
5
10
15
20
25
30

Publishers

5
10
15
20
25
30
35
40
45
American Chemical Society (ACS)
42 publications, 27.27%
Royal Society of Chemistry (RSC)
22 publications, 14.29%
Elsevier
22 publications, 14.29%
Wiley
22 publications, 14.29%
MDPI
13 publications, 8.44%
Springer Nature
8 publications, 5.19%
Taylor & Francis
6 publications, 3.9%
The Japan Institute of Heterocyclic Chemistry
4 publications, 2.6%
Georg Thieme Verlag KG
4 publications, 2.6%
Bentham Science Publishers Ltd.
2 publications, 1.3%
Frontiers Media S.A.
2 publications, 1.3%
Spandidos Publications
1 publication, 0.65%
SAGE
1 publication, 0.65%
Pleiades Publishing
1 publication, 0.65%
Walter de Gruyter
1 publication, 0.65%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.65%
Oxford University Press
1 publication, 0.65%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
154
Share
Cite this
GOST |
Cite this
GOST Copy
BAILLY C. Anticancer Properties of Lamellarins // Marine Drugs. 2015. Vol. 13. No. 3. pp. 1105-1123.
GOST all authors (up to 50) Copy
BAILLY C. Anticancer Properties of Lamellarins // Marine Drugs. 2015. Vol. 13. No. 3. pp. 1105-1123.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/md13031105
UR - https://doi.org/10.3390/md13031105
TI - Anticancer Properties of Lamellarins
T2 - Marine Drugs
AU - BAILLY, Christian
PY - 2015
DA - 2015/02/19
PB - MDPI
SP - 1105-1123
IS - 3
VL - 13
PMID - 25706633
SN - 1660-3397
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2015_BAILLY,
author = {Christian BAILLY},
title = {Anticancer Properties of Lamellarins},
journal = {Marine Drugs},
year = {2015},
volume = {13},
publisher = {MDPI},
month = {feb},
url = {https://doi.org/10.3390/md13031105},
number = {3},
pages = {1105--1123},
doi = {10.3390/md13031105}
}
MLA
Cite this
MLA Copy
BAILLY, Christian. “Anticancer Properties of Lamellarins.” Marine Drugs, vol. 13, no. 3, Feb. 2015, pp. 1105-1123. https://doi.org/10.3390/md13031105.